Combined sleep and smell signs linked to Parkinson’s marker
A spinal-fluid test was positive in 94% with a confirmed dream-enactment sleep disorder and reduced smell, versus 40% with the disorder but no reduced smell.
Limit: The abstract omits follow-up linking test results to later Parkinson’s diagnoses
Edited by Boris Djordjevic · AgingResearch.News
People with a confirmed dream-enactment sleep disorder or reduced smell joined an observational cohort before typical clinical Parkinson’s disease symptoms. Researchers used sleep recordings to confirm the disorder and smell tests to identify reduced smell. Participants underwent brain imaging and a spinal-fluid test for abnormal alpha-synuclein, a protein linked to Parkinson’s disease.
The test was positive in 94% with the sleep disorder and reduced smell, versus 40% with the disorder but no reduced smell. Among those recruited through smell testing, 85% who reported acting out dreams tested positive, versus 55% without that report. Among test-positive participants, those with reduced smell plus either the confirmed sleep disorder or reported dream enactment had more symptoms affecting mood, involuntary body functions and thinking than those with reduced smell but no reported dream enactment.
Why it matters
Parkinson’s disease is an age-related brain disorder. Identifying people at risk before typical movement symptoms could help researchers recruit participants for early-stage clinical trials.
Caveats
The abstract does not report follow-up linking test results to later Parkinson’s diagnoses. The findings are from an observational preprint that has not been peer-reviewed.
The paper
University of California San Francisco
medRxiv, Oct 28, 2026, Open access, CC BY, Preprint, not peer-reviewed
